Healthcare - Biotechnology - NASDAQ - US
$ 4.41
-8.51 %
$ 235 M
Market Cap
-4.64
P/E
Price Target
Average
172.11%
Revenue Forecast
Estimate
63.97%
EBIT
Estimate
0.58%
Net Income
Estimate
23.60%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
TScan Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TCRX of $12 , with forecasts ranging from a low of $12 to a high of $12 .
TCRX Lowest Price Target
Wall Street Target
12 USD
172.11%
TCRX Average Price Target
Wall Street Target
12 USD
172.11%
TCRX Highest Price Target
Wall Street Target
12 USD
172.11%
REVENUE FORECAST
Revenue Forecast Chart TCRX
EBIT FORECAST
EBIT Forecast Chart TCRX
NET INCOME FORECAST
Net Income Chart TCRX